article thumbnail

The Paleo Diet Launches a Paleo Certification Program for Food Packaging

XTalks

Related: Will An Upcycled Certification Mark on Packaged Foods Resonate With Consumers? Food packaging labels are branching beyond traditional categories of organic and fair trade given the rising interest among consumers for easily discernible product information. billion by 2027, growing at a compound annual growth rate (CAGR) of 3.6

article thumbnail

China’s NMPA grants priority review status for Ocumension’s Zerviate NDA

Pharmaceutical Technology

The NDA is supported by the data package licensed to Ocumension by Nicox as well as the Phase III clinical trial in China. Nicox granted exclusive license to Ocumension to develop and commercialise Zerviate in China and most of the Southeast Asian markets.

Licensing 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharma Packaging Requirements: What You Need to Know

Pharma Packaging Solutions

As biopharma products become more common, so must biopharma packaging. Due to the sensitive nature of many biological products, there are strict federal regulations in place to ensure safe packaging and distribution. Here is a brief overview of biologics packaging and labeling requirements according to the Code of Federal Regulations.

article thumbnail

Edible holograms could someday decorate foods

Scienmag

0c02438 Holograms are everywhere, from driver’s licenses to credit cards to product packaging. Credit: Adapted from ACS Nano 2021, DOI: 10.1021/acsnano.0c02438 And now, edible holograms could someday enhance foods. The edible holograms could also be used to […].

article thumbnail

US FDA accepts Sandoz’s BLA for biosimilar denosumab

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has accepted Sandoz’s biologics license application (BLA) for its proposed biosimilar denosumab. The BLA submission is supported by a comprehensive analytical and clinical data package, including the Phase I/III ROSALIA trial data.

Packaging 130
article thumbnail

Regulatory Strategy Considerations for Working with the FDA vs the EMA, Part 1

Camargo

The FDA oversees all drug approvals in the US via New Drug Applications (NDAs), with approvals for biologic products being approved via Biologics License Applications (BLAs). Meeting Package Due. The drug approval process represents one of the most obvious differences between US and EU agencies. Meeting Type. Meeting Purpose.

article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. We can’t continue to develop drugs the same way as we have done before. We need a 21st-century approach that puts patient safety first.